## Urological malignancies and the proteomicgenomic interface The urological malignancies, renal, bladder and prostate cancer, account for approximately 16% of all cancer cases. Unfortunately 5-year survival rates are relatively poor, largely a result of many cases not being diagnosed before the t
Oncogenes and urological malignancies: Implications for the future
β Scribed by Schalken, J. A. ;van den Ouweland, A. M. W. ;Debruijne, F. M. J. ;Karthaus, H. F. M. ;Van de Ven, W. J. M.
- Publisher
- Springer
- Year
- 1988
- Tongue
- English
- Weight
- 780 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Urological malignancies kill over 16 000 people annually in England and Wales. There have been exciting recent developments in our understanding of the molecular pathogenesis of these diseases, although many questions remain unanswered. Three separate genes (WT1, WT2, and WT3) have been implicated i
## Abstract A report is given on the present status of laser techniques in open as well as transurethral urological surgery. Future aspects of laser technical development and clinical applications are described and discussed.